GPP
OCRX

Great Point Partners’s Ocera Therapeutics, Inc. OCRX Stock Holding History

Great Point Partners’s Portfolio OCRX Stock Details OCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,963,777
Closed -$4.12M – 50
2016
Q4 		$4.12M Hold
1,963,777
– – 0.85% 26
2016
Q3 		$5.18M Hold
1,963,777
– – 1.32% 17
2016
Q2 		$3.73M Hold
1,963,777
– – 1.07% 24
2016
Q1 		$5.77M Hold
1,963,777
– – 2.07% 19
2015
Q4 		$6.13M Hold
1,963,777
– – 2.57% 15
2015
Q3 		$6.21M Hold
1,963,777
– – 2.45% 17
2015
Q2 		$7.46M Hold
1,963,777
– – 2.91% 13
2015
Q1 		$9.25M Sell
1,963,777
-1
-0% -$6 4.07% 6
2014
Q4 		$12.5M Buy
1,963,778
+104,463
+6% +$611K 6.02% 4
2014
Q3 		$9.11M Buy
1,859,315
+1,562,371
+526% +$9.02M 3.91% 10
2014
Q2 		$2.27M Sell
296,944
-14,877
-5% -$119K 1.01% 30
2014
Q1 		$3.29M Sell
311,821
-215,976
-41% -$3.09M 1.72% 22
2013
Q4 		$6.86M Buy
+527,797
New +$4.93M 4.84% 6

Other funds holding OCRX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Great Point Partners's OCRX Position: Q1 2017 in Review

Great Point Partners sold out of Ocera Therapeutics, Inc. (OCRX) in Q1 2017, closing a stake of 1,963,777 shares — an estimated $4.12M sold.

Great Point Partners first reported a position in OCRX in Q4 2013 and held it in 13 quarters. The position peaked at $12.5M in Q4 2014. 26 funds tracked by Wall St. Rank hold OCRX as of Q1 2017.

  • Great Point Partners reported no remaining Ocera Therapeutics, Inc. position as of Q1 2017 after selling out during the quarter.
  • Great Point Partners sold 1,963,777 Ocera Therapeutics, Inc. shares in Q1 2017, an estimated $4.12M.
  • Great Point Partners first reported a position in Ocera Therapeutics, Inc. in Q4 2013 and held it in 13 quarters.
  • Great Point Partners's Ocera Therapeutics, Inc. position peaked at $12.5M in Q4 2014.
  • 26 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q1 2017.

Based on Great Point Partners's 13F filing for Q1 2017, filed 15 May 2017.